Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-26 · accession 0001055726-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-28 | 2024-02-26 | INO | Humeau Laurent | CSO | F - Tax | $8.16 | -2,351 | 19.0K | -11% | -$19.2K |
| DM | 2024-02-28 | 2024-02-26 | INO | Humeau Laurent | CSO | M - OptEx | — | +5,734 | 22.9K | +34% | — |
| DM | 2024-02-28 | 2024-02-28 | INO | Humeau Laurent | CSO | A - Grant | $0.00 | +33.8K | 15.0K | New | $0 |
| DM | 2024-02-28 | 2024-02-26 | INO | Humeau Laurent | CSO | M - OptEx | $0.00 | -5,734 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-26 | F | D | 1,581 | $8.16 | 21,269 | D | — | — | (F5) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (4) herein. |
| 2 | Common | Common Stock | 2024-02-26 | M | A | 1,878 | — | 19,764 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. |
| 3 | Common | Common Stock | 2024-02-26 | M | A | 3,856 | — | 22,850 | D | — | — | (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units is as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 4 | Common | Common Stock | 2024-02-26 | F | D | 770 | $8.16 | 18,994 | D | — | — | (F3) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
| 5 | Derivative | Common Stock Option | 2024-02-28 | A | A | 18,750 | $0.00 | 18,750 | D | $8.46 · 2024-02-28 to 2034-02-28 | 18,750 Common Stock | (F6) The vesting schedule for the 18,750 options is as follows: 4,688 shares vested on February 28, 2024; 4,688 shares will vest on February 28, 2025; 4,687 shares will vest on February 28, 2026; and 4,687 shares will vest on February 28, 2027. |
| 6 | Derivative | Restricted Stock Unit | 2024-02-26 | M | D | 3,856 | $0.00 | 3,855 | D | — · — to — | 3,856 Common Stock | (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units is as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 7 | Derivative | Restricted Stock Unit | 2024-02-28 | A | A | 15,029 | $0.00 | 15,029 | D | — · — to — | 15,029 Common Stock | (F7) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 8 | Derivative | Restricted Stock Unit | 2024-02-26 | M | D | 1,878 | $0.00 | 0 | D | — · — to — | 1,878 Common Stock | (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. |